by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersPolleyMed, LLC

All Warning Letters

PolleyMed, LLC

Warning LetterOpen

Recipient Name John W. Polley, MD, PolleyMed, LLC, 1248 Hastings Street Traverse City , MI 49686 United States, (b)(6), (b)(7)(C)Issued May 14, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations2

Issue DateMay 14, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: PolleyMed, LLC
Location: Recipient Name John W. Polley, MD, PolleyMed, LLC, 1248 Hastings Street Traverse City , MI 49686 United States, (b)(6), (b)(7)(C)
FEI Number: N/A
Country: United States
Issue Date: May 14, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs/Misbranded

PolleyMed, LLC FDA Warning Letter, May 14, 2026